XML 55 R42.htm IDEA: XBRL DOCUMENT v3.23.2
REVENUE - Schedule of Disaggregated Revenue (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Disaggregation of Revenue [Line Items]        
Total net product sales $ 169,467 $ 169,411 $ 329,808 $ 327,402
EXPAREL        
Disaggregation of Revenue [Line Items]        
Total net product sales 135,127 137,007 265,535 266,212
ZILRETTA        
Disaggregation of Revenue [Line Items]        
Total net product sales 29,261 27,417 53,595 51,052
iovera°        
Disaggregation of Revenue [Line Items]        
Total net product sales 4,384 3,201 8,385 6,227
Bupivacaine liposome injectable suspension        
Disaggregation of Revenue [Line Items]        
Total net product sales 695 956 1,383 2,512
Total net product sales        
Disaggregation of Revenue [Line Items]        
Total net product sales $ 169,467 $ 168,581 $ 328,898 $ 326,003